Search by Drug Name or NDC
NDC 36000-0310-02 NALOXONE HYDROCHLORIDE 0.4 mg/mL Details
NALOXONE HYDROCHLORIDE 0.4 mg/mL
NALOXONE HYDROCHLORIDE is a INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is NALOXONE HYDROCHLORIDE.
Product Information
| NDC | 36000-0310 |
|---|---|
| Product ID | 36000-310_4adfd325-5c8a-477d-a3ef-5d886d44ffa3 |
| Associated GPIs | |
| GCN Sequence Number | 004516 |
| GCN Sequence Number Description | naloxone HCl VIAL 0.4 MG/ML INJECTION |
| HIC3 | H3T |
| HIC3 Description | OPIOID ANTAGONISTS |
| GCN | 17150 |
| HICL Sequence Number | 001874 |
| HICL Sequence Number Description | NALOXONE HCL |
| Brand/Generic | Generic |
| Proprietary Name | NALOXONE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | NALOXONE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Active Ingredient Strength | 0.4 |
| Active Ingredient Units | mg/mL |
| Substance Name | NALOXONE HYDROCHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214792 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 36000-0310-02 (36000031002)
| NDC Package Code | 36000-310-02 |
|---|---|
| Billing NDC | 36000031002 |
| Package | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-310-02) / 10 mL in 1 VIAL, MULTI-DOSE (36000-310-01) |
| Marketing Start Date | 2022-11-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |